Hologic Ownership
| HOLX Stock | USD 64.75 0.47 0.72% |
Hologic Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 20.73. The company has Price/Earnings To Growth (PEG) ratio of 1.23. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.Hologic Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hologic's latest congressional trading
Congressional trading in companies like Hologic, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Hologic by those in governmental positions are based on the same information available to the general public.
| 2025-04-08 | Representative Gil Cisneros | Acquired Under $15K | Verify | ||
| 2023-02-02 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2023-02-01 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2022-08-13 | Representative Susie Lee | Acquired Under $15K | Verify | ||
| 2018-12-12 | Senator John Reed | Acquired Under $15K | Verify |
Hologic Outstanding Bonds
Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Hologic 4625 percent Corp BondUS436440AM32 | View | |
| HOLOGIC INC 325 Corp BondUS436440AP62 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.